No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Changes in minimal residual disease status is associated with risk of disease progression in patients with multiple myeloma

byKathleen Lau

June 17, 2021

in StudyGraphics

#VisualAbstract: Definitive chemoradiotherapy and surgical treatment are equally effective primary interventions for patients with advanced oroparyngeal squamous cell carcinoma

RelatedReports

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

Chronic Disease

Tumour microenvironment factors may influence cancer progression and response to tamoxifen (Nolvadex) in patients with estrogen receptor-positive and human epidermal growth factor receptor 2 breast cancer

August 13, 2026

Adalimumab aids in control of noninfectious uveitis

Chronic Disease

Younger age and systemic metastases may independently predict survival among patients with choroidal metastases

August 3, 2026

Chronic Disease

A digital mental health intervention may improve anxiety in breast cancer survivors

July 31, 2026

Radiation plus hormone therapy may improve prostate cancer survival

Chronic Disease

Enzalutamide (Xtandi) and abiraterone (Zytiga) may have similar effectiveness in metastatic castration-sensitive prostate cancer

July 22, 2026

California’s cystic fibrosis newborn screening model is highly effective

Chemotherapy during the first trimester of pregnancy associated with increased risk for congenital malformations in fetus

Interventional neuroradiology procedures may deliver lens radiation doses exceeding safe thresholds

Direct to angiography in transferred patients with large vessel occlusion stroke associated with faster treatment and better outcomes vs repeat imaging approaches

Quick Take: Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma

Annual screening for ovarian cancer does not significantly reduce mortality

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract Changes in minimal residual disease status is associated with risk of disease progression in patients with multiple myeloma

RELATED REPORTS

#VisualAbstract: Definitive chemoradiotherapy and surgical treatment are equally effective primary interventions for patients with advanced oroparyngeal squamous cell carcinoma

Chemotherapy during the first trimester of pregnancy associated with increased risk for congenital malformations in fetus

RelatedReports

Recent Reports